SCHEMBL4019233

SCHEMBL4019233

C=CCN(CC=C)C(=O)CCCCCCCCC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
TSHR P16473 5/20 0.49
FAAH O00519 1/20 0.49
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
GPR84 Q9NQS5 7/20 0.43
PPARG P37231 6/20 0.43
PPARD Q03181 6/20 0.43
PPARA Q07869 6/20 0.43
HDAC11 Q96DB2 5/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
PTPN1 P18031 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
MEN1 O00255 1/20 0.43
ESR1 P03372 1/20 0.43
ALOX15 P16050 1/20 0.43
PDE4A P27815 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL570411 1.00 ALDH1A1 (0.70) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL4243964 1.00 ALDH1A1 (0.70) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL30763455 1.00 ALDH1A1 (0.70) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL11564777 1.00 ALDH1A1 (0.70) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL30763459 1.00 ALDH1A1 (0.70) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL4245319 1.00 ALDH1A1 (0.70) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL568962 0.98 ALDH1A1 (0.73) ALDH1A1TSHRFAAHCES2CES1
SCHEMBL7710302 0.92 ALDH1A1 (0.59) ALDH1A1FAAHPPARGPPARDPPARA
SCHEMBL11545896 0.92 ALDH1A1 (0.59) ALDH1A1FAAHPPARGPPARDPPARA
SCHEMBL20881785 0.91 ALDH1A1 (0.58) ALDH1A1TSHRFAAHCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2043446-A2 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT Phibro-Tech Inc. (US) 2009-04-08 EP claimed
WO-2008069822-A1 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT PHIBRO-TECH INC. (US) 2008-06-12 WO claimed
US-20080003215-A1 Use of pre-dissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol OMNIGEN RESEARCH, LLC 2008-01-03 US claimed
US-20080003660-A1 Use of fast-release pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol PHIBRO-TECH, INC. 2008-01-03 US claimed
WO-2007145858-A1 METHOD OF REDUCING THE GROWTH OF LACTOBACILLI IN A PROCESS OF ETHANOL PRODUCTION BY YEAST FERMENTATION COMPRISING ADDING A PRISTINAMYCIN-TYPE ANTIMICROBIAL AGENT AND/OR A POLYETHER IONOPHORE ANTIMICROBIAL AGENT DISSOLVED IN AN ORGANIC SOLVENT PHIBRO ANIMAL HEALTH CORPORATION (US) 2007-12-21 WO claimed
US-20070270612-A1 Biocidal azole emulsion concentrates having high active ingredient content OSMOSE, INC 2007-11-22 US claimed
WO-2007092580-A2 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT PHIBRO-TECH INC. (US) 2007-08-16 WO claimed
US-20170158840-A1 CROSSLINKABLE POLYMERIC COMPOSITIONS WITH DIALLYLAMIDE CROSSLINKING COAGENTS, METHODS FOR MAKING THE SAME, AND ARTICLES MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC 2017-06-08 US disclosed
WO-2007034511-A3 NOVEL SOLUBILITY ENHANCER AND USE THEREOF RADHAKRISHNAN RAMACHANDRAN (IN) 2009-04-09 WO disclosed
EP-2043446-A2 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT Phibro-Tech Inc. (US) 2009-04-08 EP disclosed
EP-2043446-A2 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT Phibro-Tech Inc. (US) 2009-04-08 EP disclosed
WO-2008069822-A1 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT PHIBRO-TECH INC. (US) 2008-06-12 WO disclosed
WO-2008069822-A1 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT PHIBRO-TECH INC. (US) 2008-06-12 WO disclosed
US-20070270612-A1 Biocidal azole emulsion concentrates having high active ingredient content OSMOSE, INC 2007-11-22 US disclosed
US-20070270612-A1 Biocidal azole emulsion concentrates having high active ingredient content OSMOSE, INC 2007-11-22 US disclosed
WO-2007092580-A2 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT PHIBRO-TECH INC. (US) 2007-08-16 WO disclosed
WO-2007092580-A2 BIOCIDAL AZOLE EMULSION CONCENTRATES HAVING HIGH ACTIVE INGREDIENT CONTENT PHIBRO-TECH INC. (US) 2007-08-16 WO disclosed
WO-2007034511-A2 NOVEL SOLUBILITY ENHANCER AND USE THEREOF RADHAKRISHNAN RAMACHANDRAN (IN) 2007-03-29 WO disclosed
EP-0180789-B1 CROSS-LINKING OF STYRENE POLYMERS Luperox GmbH (DE) 1990-02-28 EP disclosed
EP-0180789-A1 Cross-linking of styrene polymers Luperox GmbH (DE) 1986-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270612-A1 Biocidal azole emulsion concentrates having high active ingredient content ALK, ALKBH3, ERG28 ALDH1A1 2314/4885TSHR 4749/4885FAAH 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.